Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBasic Sciences

A Fluorinated Glucose Analog, 2-fluoro-2-deoxy-D-glucose (F-18): Nontoxic Tracer for Rapid Tumor Detection

P. Som, H. L. Atkins, D. Bandoypadhyay, J. S. Fowler, R. R. MacGregor, K. Matsui, Z. H. Oster, D. F. Sacker, C. Y. Shiue, H. Turner, C-N. Wan, A. P. Wolf and S. V. Zabinski
Journal of Nuclear Medicine July 1980, 21 (7) 670-675;
P. Som
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. L. Atkins
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. Bandoypadhyay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. S. Fowler
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. R. MacGregor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. Matsui
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Z. H. Oster
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. F. Sacker
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Y. Shiue
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Turner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C-N. Wan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. P. Wolf
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. V. Zabinski
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 21, Issue 7
July 1, 1980
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A Fluorinated Glucose Analog, 2-fluoro-2-deoxy-D-glucose (F-18): Nontoxic Tracer for Rapid Tumor Detection
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
A Fluorinated Glucose Analog, 2-fluoro-2-deoxy-D-glucose (F-18): Nontoxic Tracer for Rapid Tumor Detection
P. Som, H. L. Atkins, D. Bandoypadhyay, J. S. Fowler, R. R. MacGregor, K. Matsui, Z. H. Oster, D. F. Sacker, C. Y. Shiue, H. Turner, C-N. Wan, A. P. Wolf, S. V. Zabinski
Journal of Nuclear Medicine Jul 1980, 21 (7) 670-675;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
A Fluorinated Glucose Analog, 2-fluoro-2-deoxy-D-glucose (F-18): Nontoxic Tracer for Rapid Tumor Detection
P. Som, H. L. Atkins, D. Bandoypadhyay, J. S. Fowler, R. R. MacGregor, K. Matsui, Z. H. Oster, D. F. Sacker, C. Y. Shiue, H. Turner, C-N. Wan, A. P. Wolf, S. V. Zabinski
Journal of Nuclear Medicine Jul 1980, 21 (7) 670-675;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Cancer Metabolism Historical Perspectives: A Chronicle of Controversies and Consensus
  • Genetic evidence that uptake of the fluorescent analog 2NBDG occurs independently of known glucose transporters
  • At Last, 18F-FDG for Inflammation and Infection!
  • A Tumor Agnostic Therapeutic Strategy for Hexokinase 1-Null/Hexokinase 2-Positive Cancers
  • Cypate and Cypate-Glucosamine as Near-Infrared Fluorescent Probes for In Vivo Tumor Imaging
  • Metabolic plasticity meets gene regulation
  • Hexokinase 2 Is Targetable for HK1-Negative, HK2-Positive Tumors from a Wide Variety of Tissues of Origin
  • Modeling cancer metabolism on a genome scale
  • Optimum Lean Body Formulation for Correction of Standardized Uptake Value in PET Imaging
  • Defining Key Signaling Nodes and Therapeutic Biomarkers in NF1-Mutant Cancers
  • Reduced 64Cu Uptake and Tumor Growth Inhibition by Knockdown of Human Copper Transporter 1 in Xenograft Mouse Model of Prostate Cancer
  • In Vitro and In Vivo Characterization of 2-Deoxy-2-18F-Fluoro-D-Mannose as a Tumor-Imaging Agent for PET
  • Development of a Colon Cancer GEMM-Derived Orthotopic Transplant Model for Drug Discovery and Validation
  • Prospective Study of 2-[18F]Fluorodeoxyglucose Positron Emission Tomography in the Assessment of Regional Nodal Spread of Disease in Patients With Breast Cancer: An Ontario Clinical Oncology Group Study
  • Multimodal image coregistration and inducible selective cell ablation to evaluate imaging ligands
  • Evidence-Based Approach to the Introduction of Positron Emission Tomography in Ontario, Canada
  • One Step Closer to Imaging Vulnerable Plaque in the Coronary Arteries
  • Patterns of FDG uptake in post-thoracotomy surgical scars in patients with lung cancer
  • The radiation burden of radiological investigations
  • Synthesis and Biologic Evaluation of 64Cu-Labeled Rhenium-Cyclized {alpha}-MSH Peptide Analog Using a Cross-Bridged Cyclam Chelator
  • 99mTc- and 111In-Labeled {alpha}-Melanocyte-Stimulating Hormone Peptides as Imaging Probes for Primary and Pulmonary Metastatic Melanoma Detection
  • Positron emission tomography scanning is not superior to whole body multidetector helical computed tomography in the preoperative staging of colorectal cancer
  • Advances in paediatric tumour imaging
  • 3'-18F-Fluoro-3'-Deoxy-L-Thymidine: A New Tracer for Staging Metastatic Melanoma?
  • Prospective Comparison of 18F-FDG PET with Conventional Imaging Modalities (MRI, CT, and 67Ga Scintigraphy) in Assessment of Combined Intraarterial Chemotherapy and Radiotherapy for Head and Neck Carcinoma
  • Metabolic Fate of 18F-FDG in Mice Bearing Either SCCVII Squamous Cell Carcinoma or C3H Mammary Carcinoma
  • FDG Metabolism: Quaecumque Sunt Vera ...
  • 18-Fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancer
  • Whole-Body Hybrid PET with 18F-FDG in the Staging of Non-Hodgkin's Lymphoma
  • Evaluation of the Early Effect of Local Irradiation on Normal Rodent Bone Marrow Metabolism Using FDG: Preclinical PET Studies
  • Breast Imaging With Positron Emission Tomography and Fluorine-18 Fluorodeoxyglucose: Use and Limitations
  • Positron Emission Tomography Using [18F]Fluorodeoxyglucose for Monitoring Primary Chemotherapy in Breast Cancer
  • Google Scholar

More in this TOC Section

Basic Sciences

  • Three-Dimensional Display of Gated Cardiac Blood-Pool Studies
  • Captopril Renal Scintigraphy in a Patient with Bilateral Renal Artery Stenosis
  • Nuclear Medicine Imaging of Systemic Mastocytosis
Show more Basic Sciences

Radiochemistry and Radiopharmaceutical

  • Technetium-99m Labeling of Antibodies to Cardiac Myosin Fab and to Human Fibrinogen
  • Synthesis of “No Carrier Added” 1,3-Bis-(2-chloroethyl)nitrosourea (BCNU)
  • A New Improved Synthesis of 2-Deoxy-2-[18F]Fluoro-D-Glucose from 18F-Labeled Acetyl Hypofluorite
Show more Radiochemistry and Radiopharmaceutical

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire